title: Real-world use of quetiapine in early psychosis: An acute inpatient and community follow-up effectiveness study.
abstract: Objective. To evaluate the use of quetiapine in first episode psychosis in adolescents and adults in a 26-week open-label trial. Methods. Consenting patients were recruited from consecutive acute psychiatric admissions. Quetiapine was increased stepwise to 750 mg. Baseline, 2, 4, 12, 16, 20 and 26 week measurement included: BPRS, PANSS, CGI, and indices of tolerability and safety. Change was assessed using repeated measures ANOVA. Results. Of 73 first admission patients with psychosis, 15 entered the study. Loss of otherwise eligible patients was mainly related to prospective consent, which appeared to cause selection bias. All 15 patients were retained for 4-week Intention-to-Treat Analysis; nine completed the 26-week protocol (Completers Analysis). Non-completers dropped out shortly after 4 weeks. In the ITT Analysis, there was significant improvement on BPRS Total (P<0.01), PANSS Positive (P<0.05), and CGI (P<0.01) scores. No change in the 2-week BPRS Total score predicted subsequent non-response to quetiapine. In the Completers Analysis, onset of significant PANSS Negative score reduction did not occur until week 12. By 26 weeks all efficacy measures had substantially improved; and substance abuse was markedly less prevalent (P=0.02). Adverse events included postural hypotension, drowsiness, and significant weight gain (P=0.001).
  
  
  CONCLUSIONS
  This uncontrolled trial suggests quetiapine is an effective first-line treatment in young early psychosis patients. Prospective consent is a major barrier to evaluating acute care for psychotic disorder.
authors.affiliation: Discipline of Psychiatry, University of Queensland, Australia.
authors.forename: Stanley
authors.initials: S
authors.lastname: Victor Catts
authors.forename: Aaron
authors.initials: A
authors.lastname: Desmond James Frost
authors.forename: Shaune
authors.initials: S
authors.lastname: Gifford
authors.forename: James
authors.initials: J
authors.lastname: Scott
keywords: Atypical antipsychotic; acute care; consent; first episode psychosis; response prediction; substance abuse